BUZZ-Elevance falls as Medicare regulators plan to halt new enrollments
Reuters
Mar 02
BUZZ-Elevance falls as Medicare regulators plan to halt new enrollments
** Shares of health insurer Elevance HealthELV.N fall 3% to $310 premarket
** Co says the Centers for Medicare & Medicaid Services $(CMS)$ plans to halt new Medicare Advantage‑Prescription Drug enrollments from March 31 over concerns tied to how it submitted risk‑adjustment data before April 2023
** ELV says current members will not see changes to coverage and that it revised its practices last April; adds it is working with CMS but timing and outcome remain uncertain
** Shares fell 5% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.